/** blogpostTitle: Cyient DLM Q1 FY27: record order book and margin expansion, but cash flow stays weak blogpostSlug: cyientdlm-q1 blogpostCoverImageUrl: null blogpostCoverImageDescription: Ultra-realistic corporate finance scene showing a clean desktop dashboard with three elements: a rising quarterly revenue line ending at 3738 (in INR Mn), a bar for EBITDA margin at 10.5%, and a large stacked order book indicator reaching 25989 (INR Mn). Include subtle visuals for working-capital days as small gauges for DIO 162, DSO 77, DPO 63, and a negative cash flow indicator at -171. Neutral office lighting, no company logos or text labels. blogpostShortTitle: Cyient DLM Q1 FY27 record order book */

Cyient DLM Q1 FY27: record order book and margin expansion, but cash flow stays weak

Cyient DLM started FY27 with its strongest first-quarter performance so far, driven by steady execution and a sharp improvement in profitability. For the quarter ended 30 June 2026 (Q1 FY27), consolidated revenue rose to INR 3,738 million, up 34.3% year on year. EBITDA grew faster at INR 392 million, up 56.2%, with EBITDA margin expanding 147 basis points to 10.5%. PAT more than doubled to INR 163 million, up 118.2%, and PAT margin improved to 4.4%.

The company tied the quarter’s performance to healthy demand across its core sectors, an improving business mix, and tighter cost discipline. It also ended the quarter with its highest-ever order book since IPO, improving near-term revenue visibility.

Order book strength sets the tone

The most important operating headline in Q1 FY27 was the order book. Cyient DLM closed the quarter with an order book of INR 25,989 million and an order intake of INR 551.9 crore, translating into a book-to-bill of 1.5x. Management described the intake as being driven by both deeper engagement from existing customers and onboarding of two new client logos, added in Industrial and Automotive.

In an EMS business focused on high-mix, high-reliability work, this order book matters because it supports planning and capacity decisions. In the earnings call, management repeatedly framed the order momentum as evidence of customer confidence in Cyient DLM’s execution and positioning.

At the same time, management did not provide a numerical revenue or order book target for FY27. The clearest forward marker was the statement that the company expects to maintain a book-to-bill around 1.5x for the year.

Segment mix: Aerospace and Industrial lead, Med Tech flat

Cyient DLM’s Q1 FY27 revenue mix remained anchored in Aerospace and Industrial, with Defense as an additional meaningful contributor.

By industry, Aerospace accounted for 42% of revenue and Industrial 32%. Defense contributed 9% and Med Tech 16%, while Auto and Others was 1%.

The company highlighted strong year-on-year growth in Aerospace (40%), Industrial (90%), and Defense (35%). Med Tech was flat year on year, which management attributed to seasonality for one customer, while stating it does not see a structural concern given the pipeline in the segment.

On the product category side, PCBA made up 48% of revenue and Box Build 41%, with Mechanical and Others at 10% and Cables at 1%. The company noted PCBA grew 21% year on year and Box Build grew 85% year on year.

A major takeaway from the mix is that Cyient DLM is showing growth in the same segments it calls its “foundation” markets, while also pushing capability upgrades meant to unlock more value-added programs.

Financial snapshot (Consolidated)

Strategy: Strengthen, Expand, Transform

Management’s strategy narrative is structured around a phased roadmap.

In the Strengthen phase, the company focuses on four core industries: Aerospace and Defense, Industrial, Medical, and Automotive/EV. In the investor presentation and management commentary, this phase is positioned as a proven operating base with margins described in the 9% to 11% range.

The Expand phase, covering FY27 to FY29, aims to add two new sectors: AI Data Center and Robotics. Management described this as an extension of the “same core stack” into new end markets, with a targeted EBITDA margin profile of 11% to 13%.

The Transform phase (FY30 and beyond) is described as the step-up into a product and platform moat with expanded B2S products and new platforms, with a longer-term margin profile cited in the 13% to 18% range.

Investors pushed for clarity on what products within AI infrastructure and data centers the company intends to target. Management acknowledged the effort is still early and said it would share more detail over the next two to three quarters as the strategy and customer focus solidify.

Execution initiatives: capacity, quality, leadership

A few execution actions were specifically called out in Q1.

First, the company expanded its B2S lab capacity from 6,000 to 15,000 square feet. Management connected this to providing headroom for product-platform development and future execution.

Second, it achieved Nadcap certification for cable harness assembly at the Mysore unit. Management framed Nadcap as a demanding aerospace-grade certification that strengthens credibility in high-reliability manufacturing.

Third, Cyient DLM said it has largely completed key leadership hiring in its commercial organization, including adding a Chief Strategy and Growth Officer. The stated objective is to strengthen go-to-market capabilities and support expansion into new opportunities.

Cash flow and working capital: the key friction point

The quarter’s main area of concern was cash conversion. The investor presentation reported operation free cash flow of INR -171 million in Q1 FY27.

Working capital indicators remained elevated. Inventory days (DIO) increased to 162 from 153 in Q4 FY26. Customer advances decreased to 15 days from 18 days, and net working capital days rose to 161 from 145.

Management attributed the negative cash flow to higher inventory and lower customer advances, describing inventory investment as a leading indicator required to support growth and execution. This links to another recurring theme in the call: geopolitical disruptions and supply-chain resilience.

Management acknowledged the ongoing West Asia crisis is still causing logistics delays and higher shipment costs. It said the company mitigated the impact through proactive planning, including building inventory of critical components and alternate sourcing, which helped it avoid execution disruptions in Q1 and is expected to reduce impact in Q2.

Separately, the financial notes highlighted that other income declined sharply, primarily due to forex losses. The CFO explained that rupee appreciation during the last month of the quarter impacted the balance sheet given the company’s export and import exposure.

What to track next

Cyient DLM’s Q1 FY27 performance shows clear operational momentum, with a record order book and sustained double-digit EBITDA margins. The strategy narrative is also consistent across the presentation and call, especially the push to expand into AI infrastructure, data centers, robotics, and semiconductor capital equipment.

But the quarter also reinforces that working capital remains a meaningful swing factor. With inventory and customer advances influencing cash flow, investors will likely track whether order book conversion can happen without further cash strain.

Over the next few quarters, the market will watch for three specific proof points: execution against the record order book, clarity on product focus in AI data center and robotics, and improvement in cash flow as inventory and customer advances stabilize.